$2.7T
Total marketcap
$88.99B
Total volume
BTC 50.46%     ETH 16.76%
Dominance

Diaceutics PLC DXRX.L Stock

133 GBP {{ price }} 3.906250% {{change_pct}}%
Exchange
LSE
Market Cap
112.33M GBP
LOW - HIGH [24H]
130 - 135 GBP
VOLUME [24H]
452.04K GBP
{{ volume }}
P/E Ratio
0
Earnings per share
-0.02 GBP

Diaceutics PLC Price Chart

Diaceutics PLC DXRX.L Financial and Trading Overview

Diaceutics PLC stock price 133 GBP
Previous Close 86 GBP
Open 85.9 GBP
Bid 85 GBP x 0
Ask 0 GBP x 0
Day's Range 85.9 - 85.9 GBP
52 Week Range 74 - 118 GBP
Volume 11.63K GBP
Avg. Volume 45.3K GBP
Market Cap 74.67M GBP
Beta (5Y Monthly) 0.324964
PE Ratio (TTM) 85.9
EPS (TTM) -0.02 GBP
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 170.67 GBP

DXRX.L Valuation Measures

Enterprise Value 53.96M GBP
Trailing P/E 85.9
Forward P/E -0.2726984
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 3.8285046
Price/Book (mrq) 170.09901
Enterprise Value/Revenue 2.766
Enterprise Value/EBITDA 25.99

Trading Information

Diaceutics PLC Stock Price History

Beta (5Y Monthly) 0.324964
52-Week Change -13.99%
S&P500 52-Week Change 20.43%
52 Week High 118 GBP
52 Week Low 74 GBP
50-Day Moving Average 93.8 GBP
200-Day Moving Average 90.05 GBP

DXRX.L Share Statistics

Avg. Volume (3 month) 45.3K GBP
Avg. Daily Volume (10-Days) 120.7K GBP
Shares Outstanding 84.47M
Float 46.53M
Short Ratio N/A
% Held by Insiders 46.78%
% Held by Institutions 47.41%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) December 31, 2022
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 3.71%
Operating Margin (ttm) 2.94%
Gross Margin 85.83%
EBITDA Margin 10.64%

Management Effectiveness

Return on Assets (ttm) 0.77%
Return on Equity (ttm) 1.74%

Income Statement

Revenue (ttm) 19.5M GBP
Revenue Per Share (ttm) 0.23 GBP
Quarterly Revenue Growth (yoy) 50.10%
Gross Profit (ttm) 16.74M GBP
EBITDA 2.08M GBP
Net Income Avi to Common (ttm) 724K GBP
Diluted EPS (ttm) 0.01
Quarterly Earnings Growth (yoy) 66.40%

Balance Sheet

Total Cash (mrq) 19.84M GBP
Total Cash Per Share (mrq) 0.24 GBP
Total Debt (mrq) 1.33M GBP
Total Debt/Equity (mrq) 3.13 GBP
Current Ratio (mrq) 8.235
Book Value Per Share (mrq) 0.505

Cash Flow Statement

Operating Cash Flow (ttm) 5.1M GBP
Levered Free Cash Flow (ttm) -354625 GBP

Profile of Diaceutics PLC

Country United Kingdom
State N/A
City Belfast
Address Building Two
ZIP BT9 6GW
Phone N/A
Website https://www.diaceutics.com
Industry Diagnostics & Research
Sector(s) Healthcare
Full Time Employees 151

Diaceutics PLC, a diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. It operates DXRX platform, which offers DXRX data solutions, including access to various pipelines of diagnostic testing data from a network of laboratories that provides DXRX signal, lab mapping, testing dashboard, and physician mapping services; DXRX marketplace solutions, which enables a marketplace, where labs, pharma, and diagnostic companies come to find partners for collaborations on precision medicine diagnostics. The company also provides DXRX lab education, a suite of tailored and targeted training sessions designed to provide essential education for labs to enable and drive quality testing and biomarker knowledge; DXRX advisory boards that create and enable a valuable interface for pharmaceutical companies with a view to exploring and revealing new insights pertinent to the commercialisation and development of a therapy or companion diagnostic; and DXRX Lab Alerts, an advanced laboratory targeting service delivering tailored, short-form, quick read, educational messages with call-to-action to labs in the DXRX network. In addition, it offers implementation and consulting services for precision medicine diagnostics. Diaceutics PLC was incorporated in 2005 and is headquartered in Belfast, the United Kingdom.

Q&A For Diaceutics PLC Stock

What is a current DXRX.L stock price?

Diaceutics PLC DXRX.L stock price today per share is 133 GBP.

How to purchase Diaceutics PLC stock?

You can buy DXRX.L shares on the LSE exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Diaceutics PLC?

The stock symbol or ticker of Diaceutics PLC is DXRX.L.

Which industry does the Diaceutics PLC company belong to?

The Diaceutics PLC industry is Diagnostics & Research.

How many shares does Diaceutics PLC have in circulation?

The max supply of Diaceutics PLC shares is 844.61K.

What is Diaceutics PLC Price to Earnings Ratio (PE Ratio)?

Diaceutics PLC PE Ratio is now.

What was Diaceutics PLC earnings per share over the trailing 12 months (TTM)?

Diaceutics PLC EPS is -0.02 GBP over the trailing 12 months.

Which sector does the Diaceutics PLC company belong to?

The Diaceutics PLC sector is Healthcare.